PT

Prateek Tandon

Director Director DIN 09378056
DIN 09378056 First appointment Oct 2021 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2021
Shareholding value Locked Premium profile

About Prateek Tandon

Data last updated:

Prateek Tandon has 4 years in corporate governance. Formerly with 1 company, such as Bristol-Myers Squibb India Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09378056
Primary Designation Director
First Appointment 27 Oct 2021
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Additional Director27 Oct 20212004Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bristol-Myers Squibb India Private Limited
Premium access

Shareholding and investment profile for Prateek Tandon

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prateek Tandon

Prateek Tandon has 4 years in corporate governance. Formerly with 1 company, such as Bristol-Myers Squibb India Private Limited. Engaged in General Business. Contributes to corporate operations.

Prateek Tandon is associated with 0 companies as a director.

Prateek Tandon has expertise in General Business.

Prateek Tandon has 4 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available